Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.5M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
21.3M
-
Shares change
-
-1.29M
-
Total reported value, excl. options
-
$56.1M
-
Value change
-
-$4.25M
-
Put/Call ratio
-
0.57
-
Number of buys
-
20
-
Number of sells
-
-45
-
Price
-
$2.63
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2021
83 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2021.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.3M shares
of 55.5M outstanding shares and own 38.35% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6.39M shares), ARMISTICE CAPITAL, LLC (3.72M shares), VANGUARD GROUP INC (2.16M shares), CITADEL ADVISORS LLC (983K shares), Erste Asset Management GmbH (963K shares), BlackRock Inc. (931K shares), JPMORGAN CHASE & CO (784K shares), ACADIAN ASSET MANAGEMENT LLC (772K shares), FEDERATED HERMES, INC. (719K shares), and MORGAN STANLEY (617K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.